...
首页> 外文期刊>Experimental and therapeutic medicine >Conventional vs. pulsed-light accelerated corneal collagen cross-linking for the treatment of progressive keratoconus: 12-month results from a prospective study
【24h】

Conventional vs. pulsed-light accelerated corneal collagen cross-linking for the treatment of progressive keratoconus: 12-month results from a prospective study

机译:常规与脉冲光加速的角膜胶原蛋白交联用于治疗进步角蛋白的治疗:前瞻性研究的12个月结果

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of the present study was to compare the clinical outcomes of conventional corneal collagen cross-linking (CXL) and pulsed-light accelerated CXL (pl-ACXL) in the eyes of patients with progressive keratoconus. A total of 72 eyes with progressive keratoconus in 58 patients were equally divided into the CXL and pl-ACXL treatment groups. The CXL treatment was performed using the UVX 1000 system with 0.1% riboflavin solution in 20% dextran presoak for 30 min, and 3 mW/cm(2) ultraviolet A (UVA) light for 30 min. The pl-ACXL group was treated with the KXL system using 0.1% riboflavin with HPMC presoak for 10 min, followed by 8 min (1 sec on/1 sec off) of 30 mW/cm(2) UVA light. Patients were evaluated according to the uncorrected distance visual acuity (UDVA), corrected DVA (CDVA), refraction, maximum keratometry (Kmax), endothelial cell density (ECD), anterior segment optical coherence tomography and in vivo confocal microscopy. The follow-up period was 12 months. Transient haze was observed in 17 eyes (47.22%) in the CXL group and 8 eyes (22.22%) in the pl-ACXL group at 1 month postoperatively. There were no significant postoperative differences in the astigmatism, manifest refraction spherical equivalent, ECD or thinnest corneal thickness. By contrast, UDVA, CDVA and Kmax presented significant improvement at 12 months postoperatively in the two groups. The demarcation line depth was 284.94 +/- 33.29 mu m in the CXL group, which was significantly deeper in comparison with that in the pl-ACXL group (201.64 +/- 27.72 mu m; P<0.01) at 1 month postoperatively. In vivo confocal microscopy revealed keratocyte apoptosis and stromal edema at 1 month postoperatively, which gradually recovered towards the normal status after 12 months in the two groups. There were no apparent changes in the posterior stroma and endothelium in either group. The results of the present study revealed that CXL and pl-ACXL were safe and effective procedures in stabilizing the progression of keratoconus. The CXL technique offers more effective visual and topographic outcomes compared with pl-ACXL, while pl-ACXL ensures shorter treatment time and reduced microstructural damage.
机译:本研究的目的是将常规角膜胶原蛋白交联(CXL)和脉冲光加速CXL(PL-ACX1)的临床结果进行比较,在患者的患者的患者的眼中。在58名患者中共有72只眼睛患有进步的角蛋白酶,同等分为CXL和PL-ACX1治疗组。使用UVX 1000系统在20%葡聚糖淀粉溶液中使用UVX 1000系统进行CXL处理30分钟,3mW / cm(2)紫外线A(UVA)光30分钟。使用0.1%核黄素用HPMC PRESOAK的KXL系统处理PL-ACXL组10分钟,然后用30mW / cm(2)UVA光线为8分钟(1秒ON / 1秒)。根据未矫正的距离视力(UDVA),矫正DVA(CDVA),折射,最大角质测量(KMAX),内皮细胞密度(ECD),前段光学相干性断层扫描和体内共聚焦显微镜进行评估患者。随访期为12个月。在术后1个月,在CXL组和8只眼(22.22%)中,在17只眼(47.22%)中观察到瞬态雾霾。在散光中没有显着的术后差异,表现折射球形等效物,ECD或最薄的角膜厚度。相比之下,UDVA,CDVA和kmax在两组术后12个月内提出了显着的改善。在CXL组中,分界线深度为284.94 +/- 33.29 mu m,其在术后1个月的PL-ACXL组(201.64 +/- 27.72 mu m; P <0.01)比较中显着更深。体内共聚焦显微镜显微镜术后1个月揭示了角蛋白酶凋亡和基质水肿,这在两组中12个月后逐渐恢复正常状态。在任一组中,后基质和内皮没有明显的变化。本研究的结果表明,CXL和PL-ACXL是稳定角蛋白酶进展的安全有效的程序。与PL-ACXL相比,CXL技术提供更有效的视觉和地形结果,而PL-ACXL可确保较短的治疗时间和减少的微观结构损坏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号